| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 4921 | 1,149,529 | 1,818,733 |
| INVESTMENT - MS 8754 | 150,948 | 120,640 |
| INVESTMENT - MS 6772 | 89,331 | 89,331 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA LLC | 13,086 | 13,086 | 13,086 |
| INVESTMENT IN 4J THERAPEUTICS INC | 355,000 | 380,000 | 380,000 |
| OAKTREE STRATEGIC CREDIT FUND | 450,000 | 450,000 | 450,222 |
| HTX GYB1 0124 INVESTMENT LLC (GPG- GLYCOS BIO) | 97,755 | 97,755 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK CHARGES | 116 | 116 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MORGAN STANLEY #4921 | 33 | 33 | 33 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 3,678 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 19,898 | 19,898 | 0 | |
| MANAGEMENT FEES | 2,245 | 2,245 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 407 | 407 | 0 | |
| FEDERAL TAXES | 4,006 | 0 | 0 |